Grifols fosters world s first scientific journal specialized in blood plasma
- Plasmatology aims to become the reference publication for plasma science, bringing together the discipline s knowledge, research and scientific advances that until now lacked a specialized journal
- The prestigious Publisher SAGE Publications, specializing in scientific journals, independently edits the new international, open access, peer-reviewed online publication, which debuts March 9
News provided by
Share this article
Share this article
BARCELONA, Spain, March 8, 2021 /PRNewswire/ Grifols (MCE: GRF, MCE: GRF.P yNASDAQ: GRFS), a global leader in plasma-derived therapies with a more than 100-year track record of contributing to the health and well-being of people, today announced it s fostering the first scientific journal dedicated to the science of plasma, coinciding with the 70
Cohen Veterans Bioscience And The European College Of Neuropsychopharmacology Announce The 2021 Best Negative Data Prize In Clinical Neuroscience
Sharing Negative Science Results Is Key to Neuroscience Advancement
News provided by
Share this article
Share this article
NEW YORK, March 8, 2021 /PRNewswire/ Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP) are pleased to announce the opening of submissions for the 2021 Best Negative Data Prize in Clinical Neuroscience. The prize recognizes the researcher or research group whose publication in clinical neuroscience best exemplifies clinical data where the results do not confirm the expected outcomes or original hypotheses or results that challenge a long-standing clinical precedent.
Share this article
Share this article
RYE BROOK, N.Y., March 8, 2021 /PRNewswire/ A new survey of more than 6,500 U.S. blood cancer patients and survivors reveals that only half are very likely to get a COVID-19 vaccine while one in three is either unlikely or unsure about it. The nationwide survey was a collaboration between The Leukemia & Lymphoma Society (LLS), Boston University Questrom School of Business and The Behaviouralist, a London-based research consultancy.
The results come despite the serious risks facing blood cancer patients. Some early
studies suggest around half of blood cancer patients hospitalized with COVID-19 will die from the disease.
Sunshine Health Announces Donation of 400 Tablets to Substance Abuse Treatment Centers across Florida
Tablets to help virtually connect patients to care during pandemic
News provided by
Share this article
Share this article
TAMPA, Fla., March 8, 2021 /PRNewswire/ Today, Sunshine Health – one of the largest healthcare plans in Florida – announced its affiliate Staywell Health Plan donated 400 computer tablets to substance abuse treatment centers across Florida. The donation helps virtually connect patients and families to needed healthcare during the COVID-19 pandemic.
Employee at Operation PAR in Pinellas County unpack tablets, which will be used to stay in touch with patients during the pandemic.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period.
The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products.
Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors expected to offer strong growth opportunities for players in the recombinant proteins market. In contrast, the declining cost of recombinant proteins may restrict market growth to a certain extent.